Academic Society Condemns Off-Label Use of GLP-1 Diabetes Drugs as Shipment Curbs Persist

Hirotaka Watada, Executive Director, Japan Diabetes Society The Japan Diabetes Society (JDS) is urging doctors to stop the prescribing of diabetes-indicated GLP-1 and GIP/GLP-1 receptor agonists for aesthetic weight loss and other beauty purposes. The continued shipment controls of these...read more